The c-MET-JAK1/2-STAT3 signalling axis is a critical mediator of drug resistance in KRAS mutant colorectal cancer

Activity: Talk or presentation types › Oral presentation

PeriodNov 2012
Held atNational Cancer Research Institute, United Kingdom